𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Malignancy in HIV/AIDs: A single hospital experience

✍ Scribed by Eugene Albu; Mary Reed; Ranganath Pathak; Masooma Niazi; Mahalingam Sivakumar; Eugene Fernandes; Ravindra V. Mailapur; Vellore S. Parithivel; Paul H. Gerst

Publisher
John Wiley and Sons
Year
2000
Tongue
English
Weight
352 KB
Volume
75
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Ten years later: A single hospital exper
Ten years later: A single hospital experience with malignancy in HIV/AIDS
✍ Mary Reed; John M. Cosgrove; Richard Cindrich; Vellore S. Parithivel; Youhanna G πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 80 KB

## Abstract ## Background and Objective We present our experience in the era of HAART with 5,112 patients having HIV infection or AIDS, treated between 2002 and 2006 in our hospital, 182 of whom had malignancies (3.56%). We compared our findings to those from a similar cohort of patients studied 1

Gastric malignancy: Ten year experience
Gastric malignancy: Ten year experience at a community teaching hospital
✍ Robert P. Ruggiero; Sharon Fischer πŸ“‚ Article πŸ“… 1982 πŸ› John Wiley and Sons 🌐 English βš– 162 KB

## Abstract A ten‐year review of gastric malignancy was undertaken and several factors examined. The degree of organ involvement played a significant role in determination of survival. Surgical resection, either palliative or curative, was associated with a more favorable short‐term survival and by

Pre-AIDS mortality in the Edinburgh City
Pre-AIDS mortality in the Edinburgh City Hospital HIV Cohort
✍ Shaun R. Seaman; Ray P. Brettle; Sheila M. Gore πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 151 KB πŸ‘ 2 views

In this paper, we look at the incidence and predictive factors of pre-AIDS mortality among HIV-infected individuals, and injecting drug users (IDUs) in particular, and compare IDUs with non-IDUs. 627 patients (73 per cent IDUs) of the Edinburgh City Hospital HIV Cohort were enrolled pre-AIDS and fol

Abciximab readministration: A single-ope
Abciximab readministration: A single-operator community-hospital experience
✍ Heidar Arjomand; Zafar M. Magsi; Khai S. Chang; Daniel A.N. Mascarenhas πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 51 KB

Abciximab, a monoclonal antibody to the platelet glycoprotein IIb/IIIa receptor, reduces ischemic complications of coronary interventions after first administration. In this study, We sought to determine whether readministration of abciximab is associated with equal efficacy and safety. We retrospec